secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001213900-26-000464
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds Pharmaceuticals removes director Erik Emerson via stockholder vote
--------------------------------------------------------------------------

- Erik Emerson removed from board of directors effective December 30, 2025.
- Removal effected by majority stockholder vote, with or without cause.
- Remaining board: Elona Kogan, Jakap Koo, Carol O'Donnell, Dr. Bennett Weintraub.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/0001213900-26-000464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/ea0271636-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-000464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer